ALNY
Alnylam Pharmaceuticals, Inc.
๐บ๐ธ NYSE/NASDAQ
๐ HIGH PRICE GROWTH
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 39.76%
Annual Growth
5 years average annual growth
๐
3
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. In addition, the Company develops Cemdisiran to treat complement-mediated diseases, Belcesiran for the treatment of alpha-1 liver disease, Elebsiran, Zilebesiran, ALN-APP, ALN-HSD, Fitusiran, and others.
๐ Performance
Price History*
+204.52%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$273.92
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in ALNY
3
๐ Total Capital Earnings
N/A
๐ Average investment frequency
26 weeks
๐ต Average investment amount
$663
โฐ Last time a customer invested in ALNY
16 days
ALNY investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
67%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
33%
35 - 90
67%
๐ Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in ALNY also invest in...
๐ Performance (5Yr p.a)
17.19%
๐ Share price
$524.95 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
11.76%
๐ Share price
$46.64 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
3.24%
๐ Share price
$209.19 USD
๐ Performance (5Yr p.a)
1043.13%
๐ Share price
$171.29 USD
๐ Performance (5Yr p.a)
40.68%
๐ Share price
$287.49 USD
๐ HIGH PRICE GROWTH
Want more shares? Try these...